Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ReposiTrak's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ReposiTrak's regulatory disclosures and financial reporting.
ReposiTrak, Inc. (TRAK) insider Randall K. Fields, who is a director, 10% owner and chief executive officer, reported automatic sales of common stock by an affiliated charitable entity. On 11/17/2025, 11/19/2025, and 11/20/2025, RK Fields Charitable 2022, LLC sold 1,000, 4,500 and 2,000 shares of ReposiTrak common stock, respectively, at weighted average prices of $14.807, $14.0109 and $13.4659. The filing states these transactions were executed under a pre-established Rule 10b5-1 trading plan designed to help Fields meet charitable commitments. Following these trades, Fields continues to report significant holdings, including 3,683,955 shares of common stock held directly, plus additional common and Series B preferred shares held indirectly through entities and a spouse.
ReposiTrak, Inc. reported the results of its Annual Meeting of Stockholders held on November 19, 2025. Stockholders elected four directors — Randall K. Fields, Robert W. Allen, Ronald C. Hodge and Peter J. Larkin — each by a plurality of votes cast, with support of more than 9.4 million votes for each nominee.
Stockholders also approved, on a non-binding advisory basis, the executive compensation program, with approximately 9.4 million votes cast in favor versus smaller amounts against or abstaining. In a separate advisory vote on how often to hold future say-on-pay votes, the largest number of votes, about 7.3 million, supported holding the vote every three years, and the Board determined that frequency going forward.
Additionally, stockholders ratified the appointment of Haynie & Company as the Company’s independent registered public accounting firm. These outcomes confirm continuity in the Company’s board composition, executive pay approach, and audit arrangements.
ReposiTrak, Inc. reported that it has released its financial results for the fiscal quarter ended September 30, 2025. The company issued a press release and held an earnings call on November 13, 2025 to discuss these results. The press release and the full earnings call transcript are provided as exhibits to this report, giving investors access to detailed quarterly performance information and management’s commentary. The common stock of ReposiTrak continues to trade on the New York Stock Exchange under the symbol TRAK.
ReposiTrak, Inc. (TRAK) reported Q1 FY2026 results. Revenue was $5,971,467, up 10% year over year, driven by recurring subscription and support services of $5,941,467. Net income was $1,819,529, and diluted EPS was $0.09. Income from operations reached $1,893,873.
Cash and cash equivalents were $28,794,806, with deferred revenue of $2,686,197 and no bank debt. Operating cash flow was $1,538,447. The company redeemed 70,093 shares of Series B Preferred for $749,995 and repurchased 8,715 common shares for $149,985. A quarterly cash dividend of $0.02 per share was declared. As of November 13, 2025, 18,288,455 common shares were outstanding.
Management highlights growth across compliance, supply chain, and traceability offerings as industry mandates expand. Total stockholders’ equity increased to $50,169,744.
ReposiTrak, Inc. (TRAK): CEO, director and 10% owner Randall K. Fields reported two open‑market sales under a Rule 10b5‑1 plan. On 11/10/2025, the RK Fields Charitable 2022, LLC sold 1,600 shares at a weighted average price of $15.0326. On 11/11/2025, it sold 5,900 shares at a weighted average price of $15.0248.
Following these transactions, the charitable LLC held 12,500 shares indirectly. Additional reported holdings include 3,683,955 shares directly; 615,260 shares indirectly by Riverview Financial Corp.; 333,643 shares indirectly by Fields Management, Inc.; 30,667 shares indirectly by spouse; and Series B Preferred holdings of 229,262 shares indirectly by Riverview Financial Corp. and 5,320 shares indirectly by spouse. The filing notes the plan was established to meet charitable commitments.
ReposiTrak (TRAK) disclosed an insider transaction on a Form 4. CEO, Director and 10% owner Randall K. Fields reported a sale of 7,500 shares of common stock on 11/03/2025 at a weighted average price of $15.0126, executed under a Rule 10b5-1 trading plan to meet charitable commitments. The filing notes the shares were sold in multiple trades between $15.00 and $15.10. Following the transaction, reported holdings include 3,683,955 shares direct and various indirect positions, including 20,000 by RK Fields Charitable 2022, LLC.
ReposiTrak (TRAK) disclosed insider transactions by Randall K. Fields, its Chief Executive Officer, director, and 10% owner. Acting through RK Fields Charitable 2022, LLC under a Rule 10b5-1 trading plan, he sold a total of 7,500 shares across three days: 3,800 shares on 10/28/2025 at a weighted average price of $15.2786, 1,000 shares on 10/29/2025 at $15.1774, and 2,700 shares on 10/30/2025 at $14.9978. The plan was established to meet charitable commitments.
Following the reported transactions, beneficial holdings included 27,500 shares indirectly by RK Fields Charitable 2022, LLC and 3,683,955 shares held directly, with additional indirect holdings reported through Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as Series B Preferred Stock holdings.
ReposiTrak, Inc. (TRAK) CEO, Director, and 10% owner Randall K. Fields reported a sale of common stock on 10/20/2025. The filing shows a disposition of 7,500 shares coded “S,” executed under a Rule 10b5-1 trading plan established to meet charitable commitments.
The weighted average sale price was $15.467, with individual trades ranging from $14.80 to $15.21. Following the reported transaction, the filing lists 35,000 shares indirectly held by RK Fields Charitable 2022, LLC.
Additional beneficial holdings disclosed include 3,683,955 shares (direct), 615,260 shares indirectly by Riverview Financial Corp., 30,667 shares indirectly by spouse, and 333,643 shares indirectly by Fields Management, Inc. The filing also lists Series B Preferred Stock positions: 289,673 shares indirectly by Riverview Financial Corp. and 6,721 shares indirectly by spouse.
ReposiTrak (TRAK) disclosed that CEO, director and 10% owner Randall K. Fields sold a total of 7,500 shares of common stock on October 14–15, 2025 under a Rule 10b5-1 trading plan executed through RK Fields Charitable 2022, LLC, established to help meet charitable commitments.
Transactions included: 1,500 shares at a weighted average price of $14.7377 on 10/14, 1,640 shares at $14.4227 on 10/14, and 4,360 shares at $14.4227 on 10/15. Following these sales, the filing shows 42,500 shares held indirectly by the charitable LLC and 3,683,955 shares held directly, alongside additional indirect holdings through affiliated entities.
Randall K. Fields, who serves as Chief Executive Officer, Director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a sale of 7,500 shares of common stock on 10/07/2025 at a weighted average price of $14.9711 per share under a Rule 10b5-1 trading plan. The filing shows substantial remaining holdings: 3,683,955 shares held directly, 615,260 shares indirectly via Riverview Financial Corp., 333,643 via Fields Management, Inc., and other indirect holdings including 50,000 shares held by RK Fields Charitable 2022, LLC.
The sale was executed automatically to satisfy charitable commitments and occurred across multiple transactions with prices ranging from $14.16 to $15.21. No derivative securities were reported as changed in this filing.